Exosome-Mediated Delivery of CRISPR/Cas9 for Targeting of Oncogenic Kras^G12D in Pancreatic Cancer

Reseachers showed that non-autologous exosomes could encapsulate CRISPR/Cas9 plasmid DNA via commonly available transfection reagents and could be delivered to recipient cancer cells to induce targeted gene deletion.